Who Paid My Doc
An Open-Label Extension Trial of the Phase III Lipid-Lowering Trials to Assess the Effect of Long Term Dosing of Inclisiran Given As Subcutaneous Injections in Subjects With High Cardiovascular Risk and Elevated LDL-C
Research payments
$8,249,454
Through program year 2024, $8,249,454 in research payments was reported against An Open-Label Extension Trial of the Phase III Lipid-Lowering Trials to Assess the Effect of Long Term Dosing of Inclisiran Given As Subcutaneous Injections in Subjects With High Cardiovascular Risk and Elevated LDL-C, across 521 payments, paid by Novartis Pharmaceuticals Corporation.
- Paid by
- Novartis Pharmaceuticals Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $21,500 | 5 |
| 2023 | Research | $714,603 | 141 |
| 2022 | Research | $3,689,261 | 134 |
| 2021 | Research | $1,840,444 | 119 |
| 2020 | Research | $1,983,646 | 122 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Michael Butcher Cincinnati, OH Named on 6 payments
- Neil Fraser Troy, MI Named on 5 payments
- James Lovell West Des Moines, IA Named on 4 payments
- Ahmed Arif Flint, MI Named on 3 payments
- John Pullman Butte, MT Named on 3 payments
- Vicki Kalen Tucson, AZ Named on 3 payments
- Antonio Terrelonge Miami, FL Named on 3 payments
- Hessam Aazami Canoga Park, CA Named on 3 payments
- Manfouz El Shahawy Sarasota, FL Named on 3 payments
- Lilia Rodriguez Ables Miami, FL Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.